title: Does hemodialysis affect clopidogrel resistance as measured by VerifyNow P2Y12 test?
authors.forename: Abdallah S
authors.initials: AS
authors.lastname: Geara
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ayoub
authors.forename: Jacques
authors.initials: J
authors.lastname: Abi Rached
authors.forename: Muhammad N
authors.initials: MN
authors.lastname: Siddique
authors.forename: Pratima
authors.initials: P
authors.lastname: Ghimire
authors.forename: Suzanne
authors.initials: S
authors.lastname: El-Sayegh
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D000077144:Clopidogrel; D004351:Drug Resistance; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood; D008134:Long-Term Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests; D011183:Postoperative Complications / Q000188:drug therapy; D011237:Predictive Value of Tests; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D058925:Receptors, Purinergic P2Y12 / Q000097:blood*; D006435:Renal Dialysis; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: C548576:P2RY12 protein, human; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D000077144:Clopidogrel; D013988:Ticlopidine